share_log

Vicarious Surgical (NYSE:RBOT) Stock Price Down 4.6%

Vicarious Surgical (NYSE:RBOT) Stock Price Down 4.6%

Vicarious Surgical（纽约证券交易所代码：RBOT）股价下跌4.6％
Defense World ·  2023/01/31 01:52

Vicarious Surgical Inc (NYSE:RBOT – Get Rating) shares were down 4.6% during trading on Monday . The stock traded as low as $2.66 and last traded at $2.68. Approximately 144,413 shares were traded during mid-day trading, a decline of 61% from the average daily volume of 372,564 shares. The stock had previously closed at $2.81.

Surgical公司(纽约证券交易所代码：RBOT-GET)的股票在周一的交易中下跌了4.6%。该股一度跌至2.66美元，最后报2.68美元。午盘成交量约为144,413股，较372,564股的日均成交量下降61%。该股此前收盘价为2.81美元。

Vicarious Surgical Price Performance

替代手术性价比

The firm has a market cap of $327.95 million, a price-to-earnings ratio of 3.77 and a beta of 1.09. The business has a fifty day simple moving average of $2.56 and a 200 day simple moving average of $3.35.

该公司市值为3.2795亿美元，市盈率为3.77倍，贝塔系数为1.09。该业务的50日简单移动均线切入位为2.56美元，200日简单移动均线切入位为3.35美元。

Get
到达
Vicarious Surgical
代替性外科
alerts:
警报：

Vicarious Surgical (NYSE:RBOT – Get Rating) last released its quarterly earnings results on Monday, November 7th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.03). During the same period in the previous year, the firm earned ($0.09) earnings per share. On average, research analysts anticipate that Vicarious Surgical Inc will post -0.66 earnings per share for the current fiscal year.

Surgical(纽约证券交易所代码：RBOT-GET Rating)最近一次发布季度收益报告是在11月7日星期一。该公司公布本季度每股收益(EPS)为0.18美元，低于分析师一致预期的0.15美元和0.03美元。去年同期，该公司每股收益为0.09美元。研究分析师平均预计，维珍外科公司本财年的每股收益将为0.66美元。

Insider Buying and Selling at Vicarious Surgical

代理外科公司的内幕买卖

In other news, Director Philip Liang sold 15,000 shares of the stock in a transaction that occurred on Thursday, November 10th. The shares were sold at an average price of $3.59, for a total value of $53,850.00. Following the completion of the transaction, the director now directly owns 1,185,320 shares in the company, valued at $4,255,298.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at
在其他新闻方面，董事菲利普·梁在11月10日星期四的一笔交易中出售了15,000股该股。这些股票的平均价格为3.59美元，总价值为53,850.00美元。交易完成后，董事现在直接拥有该公司1185,320股票，价值4,255,298.80美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可在
this hyperlink
此超链接
. In other Vicarious Surgical news, Director Philip Liang sold 15,000 shares of Vicarious Surgical stock in a transaction on Thursday, November 10th. The shares were sold at an average price of $3.59, for a total transaction of $53,850.00. Following the completion of the sale, the director now owns 1,185,320 shares of the company's stock, valued at approximately $4,255,298.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at
。另有消息称，11月10日(星期四)，董事菲利普·梁在一笔交易中出售了15,000股代理外科股票。这些股票以3.59美元的平均价格出售，总成交金额为53,850.00美元。出售完成后，董事现在拥有1,185,320股该公司股票，价值约4,255,298.80美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可在
this link
这个环节
. Also, CTO Sammy Khalifa sold 18,041 shares of Vicarious Surgical stock in a transaction on Monday, November 21st. The shares were sold at an average price of $3.29, for a total transaction of $59,354.89. Following the sale, the chief technology officer now directly owns 994,493 shares of the company's stock, valued at approximately $3,271,881.97. The disclosure for this sale can be found
。此外，首席技术官萨米·哈利法在11月21日星期一的一次交易中出售了18,041股代理外科股票。这些股票以3.29美元的平均价格出售，总成交金额为59,354.89美元。出售后，这位首席技术官现在直接持有该公司994,493股股票，价值约3,271,881.97美元。关于这次销售的披露可以找到
here
这里
. Insiders sold a total of 117,873 shares of company stock valued at $376,819 in the last ninety days. Insiders own 52.48% of the company's stock.
。在过去的90天里，内部人士总共抛售了117,873股公司股票，价值376,819美元。内部人士持有该公司52.48%的股份。

Institutional Trading of Vicarious Surgical

代用外科手术的制度性交易

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RBOT. International Assets Investment Management LLC acquired a new position in Vicarious Surgical during the fourth quarter worth $27,000. Strs Ohio increased its holdings in Vicarious Surgical by 395.3% in the 4th quarter. Strs Ohio now owns 62,900 shares of the company's stock valued at $127,000 after buying an additional 50,200 shares during the period. Rothschild Investment Corp IL increased its holdings in Vicarious Surgical by 28.5% in the 4th quarter. Rothschild Investment Corp IL now owns 168,831 shares of the company's stock valued at $341,000 after buying an additional 37,417 shares during the period. Twelve Points Wealth Management LLC increased its holdings in Vicarious Surgical by 86.0% in the 4th quarter. Twelve Points Wealth Management LLC now owns 100,473 shares of the company's stock valued at $203,000 after buying an additional 46,462 shares during the period. Finally, Riverwater Partners LLC grew its holdings in shares of Vicarious Surgical by 63.0% during the 4th quarter. Riverwater Partners LLC now owns 27,853 shares of the company's stock valued at $56,000 after purchasing an additional 10,762 shares during the last quarter. Institutional investors own 42.77% of the company's stock.

一些机构投资者和对冲基金最近增持或减持了RBOT的股份。国际资产投资管理有限责任公司在第四季度获得了一个新的头寸，价值27,000美元。俄亥俄州STRS在第四季度增持了395.3%的Surgical。STR俄亥俄州现在拥有62,900股该公司的股票，价值12.7万美元，在此期间又购买了50,200股。Rothschild Investment Corp IL在第四季度增持了Surgical公司28.5%的股份。Rothschild Investment Corp IL目前持有168,831股该公司股票，价值341,000美元，在此期间又购买了37,417股。十二点财富管理有限责任公司第四季度增持维信外科86.0%的股份。十二点财富管理公司现在拥有100,473股该公司的股票，价值203,000美元，在此期间又购买了46,462股。最后，Riverwater Partners LLC在第四季度增持了Vicary Surgical的股份63.0%。Riverwater Partners LLC现在拥有27,853股该公司的股票，价值56,000美元，在上个季度又购买了10,762股。机构投资者持有该公司42.77%的股票。

Vicarious Surgical Company Profile

代理外科公司简介

(Get Rating)

(获取评级)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

替代外科公司在美国作为一家机器人技术公司运营。该公司专注于开发和商业化维多利亚系统，这是一种单切口手术机器人，可以虚拟地将外科医生运送到患者体内进行微创手术。Surgical Inc.成立于2014年，总部设在马萨诸塞州沃尔瑟姆。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Vicarious Surgical (RBOT)
  • Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
  • SoFi Technologies Smashes Earnings but Beware the Fed Decision
  • Buying The Dip In Colgate-Palmolive
  • Mullen Automotive On Hiring Spree, What Could That Mean?
  • InterDigital Raises Its Earnings Guidance
  • 免费获取StockNews.com关于替代外科手术(RBOT)的研究报告
  • 为什么黄金现在可以成为你投资组合中的闪闪发光的一部分
  • 索菲技术公司盈利惨淡，但要警惕美联储的决定
  • 购买高露洁棕榄中的Dip
  • 马伦汽车(Mullen Automotive)大举招聘，这可能意味着什么？
  • InterDigital上调盈利指引

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《替代外科日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯，接收对替代外科及相关公司的最新新闻和分析师评级的每日简要摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发